Rochester, N.Y. (WKBW release) -- U.S. Attorney William J. Hochul, Jr. announced Wednesday that Andrew Russell, 25, of Rochester, N.Y., was arraigned on the first-of-its-kind prosecution involving 4-Ethyl-N-ethylcathinone, a controlled substance analogue, more popularly known as “Bath Salts” or “Molly."
The specific charge is a violation of Title 21, United States Code, Section 841(a)(1), which carries a maximum penalty of 20 years in prison, a $1,000,000 fine, or both.
Assistant U.S. Attorney Douglas E. Gregory, who is handling the case, stated that on July 25, 2011, Russell was stopped in his motor vehicle by members of the Rochester Police Department. At that time, Russell is alleged to have been in possession of approximately 277 grams of a powdery substance. A subsequent chemical test of the substance by the Drug Enforcement Administration revealed the presence of 4-Ethyl-N-ethylcathinone. Russell is also alleged to have possessed more than $2,000 in cash.
“The public needs to be aware that substances commonly known as ‘Bath Salts’ or ‘Molly’ are an emerging public health threat, and that anyone who attempts to ingest them faces a serious health risk,” said U.S. Attorney Hochul. “For these reasons, the DEA, along with many of our local law enforcement agencies, have recently ramped up their efforts to combat the importation, distribution, and use of designer drugs, of which ‘Bath Salts’ and ‘Molly’ are examples.”
"Bath Salts" have a similar chemical structure to “methcathinone,” a Schedule I controlled substance that has the properties and effect of a stimulant. Contrary to its name, “Bath Salts” have no real value as a bath salt or other bath product.